DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Símbolo de cotizaciónDRIO
Nombre de la empresaDarioHealth Corp
Fecha de salida a bolsaMar 08, 2013
Director ejecutivoMr. Erez Raphael
Número de empleados196
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 08
Dirección322 W 57Th St. #33B
CiudadNEW YORK
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal10019
Teléfono16466654667
Sitio Webhttps://shop.mydario.com/
Símbolo de cotizaciónDRIO
Fecha de salida a bolsaMar 08, 2013
Director ejecutivoMr. Erez Raphael
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos